Overview
Bonafarm Spółka Z Ograniczoną Odpowiedzialnoscią is a Polish pharmaceutical company that has been operating since 2013, specializing in the research, development, and commercialization of dietary supplements. The company focuses on creating products that support proper body functioning and contain carefully selected, standardized extracts and innovative substances. They emphasize the importance of informed and rational choices regarding dietary supplements, which differ from medications.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2013-06-10. Active
50 1050 1445 1000 0090 8463 6092- 15 1050 1445 1000 0090 3018 0146
- 20 1050 1445 1000 0090 3018 0153
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 25, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,089$2,089 | Prezes Banku Gospodarstwa Krajowego |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
For making declarations of will on behalf of the company in non-property matters and property matters with a value not exceeding PLN 50,000 (fifty thousand złoty), two members of the management board acting jointly are authorised. For making declarations of will on behalf of the company in property matters with a value exceeding PLN 50,000 (fifty thousand złoty), three members of the management board acting jointly are authorised.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Peter Michael Jankowski (45) | 136 | $3,673.69 | 24.7273% |
Janusz Sławomir Szot (45) | 207 | $5,591.57 | 37.6364% |
Paweł Wojciech Zakrocki (46) | 207 | $5,591.57 | 37.6364% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Janusz Sławomir Szot (45)  | Shareholder of a limited liability company, 20700.0 PLN | |
Paweł Wojciech Zakrocki (46) | Shareholder of a limited liability company, 20700.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fharmfoodsp. z o.o. | $1,736,997.29 | fharmfood.eu | ||
| Lab88sp. z o.o. | $1,707,981.35 | lab88.pl | ||
| Bionatursp. z o.o. + limited partnership | $1,192,779.68 | bionatur.pl | ||
| Suplement.Iosp. z o.o. | $1,149,843.38 | suplement.io | ||
| IOCsp. z o.o. | $878,940.46 | producentsuplementow.pl | ||
| Pharmavenesp. z o.o. | $783,187.61 | pharmavene.com | ||
| NPA Fumumsp. z o.o. | $671,612.80 | fumum.pl | ||
| Colostrum Polskasp. z o.o. | $587,012.72 | colostrumpolska.pl | ||
| PET Futura Solutionsp. z o.o. | $395,947.32 | petfuturasolution.com | ||
| Amberpharmsp. z o.o. | $300,044.02 | amberpharm.eu |
Change history
| Date | Event | |
|---|---|---|
| 2016-05-17 | PKD change (Removed: 21.10.Z, 46.1, 46.38.Z, 46.39.Z, 46.45.Z, 46.90.Z, 47.11.Z, 47.19.Z, 47.29.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.91.Z, 47.99.Z, 63.99.Z, 70.21.Z, 70.22.Z, 73.1, 73.11.Z, 73.12.B, 73.12.C, 73.20.Z, 77.40.Z, 82.20.Z, 82.30.Z, 85.59.B) | |
| 2015-03-13 | Share capital change (10,200.00 PLN → 55,000.00 PLN) | |
| 2013-06-03 | Entered in the register |
FAQ
Last updated: 2026-07-05